Moreover, GM-CSF has been used to effectively induce immune tolerance in animal models of experimental autoimmune disease, including myasthenia gravis and diabetes, and the beneficial effect of GM-CSF therapy in these diseases was shown to be mediated through the promotion of tolerogenic DCs and the expansion of Tregs [22], [23]. Here, CSF2 is linked to diabetes mellitus.